Assessing trends in breast care surveillance metrics after implementing surgeon‐specific tracking and performance reporting in a large, integrated cancer network

AbstractBackgroundThere are few quality metrics and benchmarks specific to surgical oncology. Development of a surgeon‐level performance metrics system based on peer comparisons is hypothesized to positively influence surgical decision‐making. This study established a tracking and reporting system comprised of evidence and consensus‐based metrics to assess breast care delivered by individual surgeons.MethodsSurgeons’ performance is assessed by a surveillance tracking system of metrics pertaining to referrals and surgical elements. This retrospective analysis of prospectively collected breast care data reports on recurring 6‐month and cumulative data from nine care locations from 2015 to 2021.ResultsBreast care was provided to 6659 patients by 41 surgeons. A total of 27 breast care metrics were evaluated over 7 years. Metrics with consistent, proficient results were retired after 18 months, including the rate of core biopsy, specimen orientation, and referrals to medical oncology, genetics, and fertility, among others. In clinically node‐negative, hormone receptor‐positive patients 70 years of age or older, the cumulative rate of sentinel lymph node (SLN) biopsy significantly decreased by 40% over 5.5 years (p < .001). The overall breast conservation rate for T0–T2 cancer increased 10% over 7 years. At the surgeon level, improvements were made in the median number of SLNs removed and in operative note documentation.ConclusionsImplementation of a surgeon‐specific, peer comparison‐based metric and tracking system has yielded substantive changes in breast care management. This process and governance structure can serve as a model for quantification of breast care at other institutions and for other disease sites.